Zdeňka Vaňourková

846 total citations
43 papers, 710 citations indexed

About

Zdeňka Vaňourková is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Biochemistry. According to data from OpenAlex, Zdeňka Vaňourková has authored 43 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 28 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Biochemistry. Recurrent topics in Zdeňka Vaňourková's work include Renin-Angiotensin System Studies (27 papers), Hormonal Regulation and Hypertension (25 papers) and Eicosanoids and Hypertension Pharmacology (11 papers). Zdeňka Vaňourková is often cited by papers focused on Renin-Angiotensin System Studies (27 papers), Hormonal Regulation and Hypertension (25 papers) and Eicosanoids and Hypertension Pharmacology (11 papers). Zdeňka Vaňourková collaborates with scholars based in Czechia, Germany and Poland. Zdeňka Vaňourková's co-authors include Luděk Červenka, Zuzana Husková, Herbert J. Kramer, Petra Škaroupková, Ivana Vaněčková, Monika Thumová, Libor Kopkan, Martin Opočenský, Věra Čertíková Chábová and Janusz Sadowski and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Hypertension.

In The Last Decade

Zdeňka Vaňourková

41 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zdeňka Vaňourková Czechia 17 508 426 252 137 100 43 710
Petra Škaroupková Czechia 20 611 1.2× 418 1.0× 291 1.2× 159 1.2× 128 1.3× 48 863
Monika Thumová Czechia 15 324 0.6× 294 0.7× 138 0.5× 64 0.5× 124 1.2× 17 480
Věra Čertíková Chábová Czechia 16 352 0.7× 305 0.7× 238 0.9× 120 0.9× 49 0.5× 34 720
Kentaro Ohtoshi Japan 10 152 0.3× 287 0.7× 74 0.3× 107 0.8× 95 0.9× 12 572
Fabrice M A C Martens Netherlands 10 200 0.4× 221 0.5× 61 0.2× 126 0.9× 254 2.5× 25 609
Minolfa C. Prieto‐Carrasquero United States 10 629 1.2× 528 1.2× 62 0.2× 59 0.4× 256 2.6× 20 880
Jürgen R. Schaefer Germany 5 110 0.2× 175 0.4× 189 0.8× 120 0.9× 74 0.7× 11 500
Sandra Feldt Germany 10 663 1.3× 548 1.3× 53 0.2× 51 0.4× 304 3.0× 11 863
Takeaki Honda Japan 12 273 0.5× 182 0.4× 46 0.2× 98 0.7× 147 1.5× 15 557
Tobias Riexinger Germany 5 290 0.6× 77 0.2× 101 0.4× 98 0.7× 53 0.5× 8 569

Countries citing papers authored by Zdeňka Vaňourková

Since Specialization
Citations

This map shows the geographic impact of Zdeňka Vaňourková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdeňka Vaňourková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdeňka Vaňourková more than expected).

Fields of papers citing papers by Zdeňka Vaňourková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zdeňka Vaňourková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdeňka Vaňourková. The network helps show where Zdeňka Vaňourková may publish in the future.

Co-authorship network of co-authors of Zdeňka Vaňourková

This figure shows the co-authorship network connecting the top 25 collaborators of Zdeňka Vaňourková. A scholar is included among the top collaborators of Zdeňka Vaňourková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdeňka Vaňourková. Zdeňka Vaňourková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chlupáč, Jaroslav, David Sedmera, Zdeňka Vaňourková, et al.. (2024). External Support of Autologous Internal Jugular Vein Grafts with FRAME Mesh in a Porcine Carotid Artery Model. Biomedicines. 12(6). 1335–1335.
2.
Kala, Petr, Zuzana Husková, Zdeňka Vaňourková, et al.. (2024). Renal denervation improves cardiac function independently of afterload and restores myocardial norepinephrine levels in a rodent heart failure model. Hypertension Research. 47(10). 2718–2730. 4 indexed citations
3.
Husková, Zuzana, Petra Škaroupková, Zdeňka Vaňourková, et al.. (2023). The treatment with sGC stimulator improves survival of hypertensive rats in response to volume-overload induced by aorto-caval fistula. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(12). 3757–3773. 10 indexed citations
4.
Hojná, Silvie, Zdeňka Vaňourková, Hana Rauchová, et al.. (2022). Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease. Biomedicines. 10(10). 2509–2509. 8 indexed citations
5.
Kala, Petr, Zdeňka Vaňourková, Petra Škaroupková, et al.. (2022). Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5/6 nephrectomized rats with aorto-caval fistula. Biomedicine & Pharmacotherapy. 158. 114157–114157. 10 indexed citations
6.
Hojná, Silvie, Hana Rauchová, Hana Malínská, et al.. (2021). Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension. Biomedicine & Pharmacotherapy. 144. 112246–112246. 16 indexed citations
7.
Husková, Zuzana, Agnieszka Walkowska, Janusz Sadowski, et al.. (2020). Combined treatment with epoxyeicosatrienoic acid analog and 20-hydroxyeicosatetraenoic acid antagonist provides substantial hypotensive effect in spontaneously hypertensive rats. Journal of Hypertension. 38(9). 1802–1810. 13 indexed citations
8.
Chábová, Věra Čertíková, Libor Kopkan, Zdeňka Vaňourková, et al.. (2017). Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20-Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney. The American Journal of the Medical Sciences. 353(6). 568–579. 9 indexed citations
9.
Walkowska, Agnieszka, Petra Škaroupková, Zuzana Husková, et al.. (2010). Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats. Journal of Hypertension. 28(3). 582–593. 23 indexed citations
10.
Bürgelová, Marcela, Ivana Vaněčková, Zdeňka Vaňourková, et al.. (2010). Knockout of Angiotensin 1–7 Receptor Mas Worsens the Course of Two-Kidney, One-Clip Goldblatt Hypertension: Roles of Nitric Oxide Deficiency and Enhanced Vascular Responsiveness to Angiotensin II. Kidney & Blood Pressure Research. 33(6). 476–488. 31 indexed citations
11.
Vaněčková, Ivana, Zuzana Husková, Zdeňka Vaňourková, & Luděk Červenka. (2010). Castration Has Antihypertensive and Organoprotective Effects in Male but Not in Female Heterozygous Ren-2 Rats. Kidney & Blood Pressure Research. 34(1). 46–52. 11 indexed citations
12.
Bürgelová, Marcela, Zdeňka Vaňourková, Monika Thumová, et al.. (2009). Impairment of the angiotensin-converting enzyme 2–angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. Journal of Hypertension. 27(10). 1988–2000. 54 indexed citations
13.
Červenka, Luděk, Ivana Vaněčková, Zuzana Husková, et al.. (2008). Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice. Journal of Hypertension. 26(7). 1379–1389. 54 indexed citations
14.
Vernerová, Zdeňka, Herbert J. Kramer, Angela Bäcker, et al.. (2008). Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats. Vascular Pharmacology. 48(4-6). 165–173. 16 indexed citations
15.
Vaněčková, Ivana, Libor Kopkan, Zuzana Husková, et al.. (2007). AT1 receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats. Vascular Pharmacology. 47(1). 63–67. 5 indexed citations
16.
Husková, Zuzana, Herbert J. Kramer, Libor Kopkan, et al.. (2007). Effects of dietary salt load and salt depletion on the development of hypertension and angiotensin II levels in Cyp1a1-Ren-2 transgenic rats. Hypertension. 50(4). 1 indexed citations
17.
Vaněčková, Ivana, Libor Kopkan, Zuzana Husková, et al.. (2007). Long-Term Prevention of Hypertension and End-Organ Damage in Ren-2 Transgenic Rats Is Achieved Only with Persistent but Not Transient AT<sub>1 </sub>Receptor Blockade. Kidney & Blood Pressure Research. 30(1). 38–44. 4 indexed citations
18.
Husková, Zuzana, Herbert J. Kramer, Zdeňka Vaňourková, & Luděk Červenka. (2006). Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats. Journal of Hypertension. 24(3). 517–527. 40 indexed citations
19.
Vaňourková, Zdeňka, Herbert J. Kramer, Zuzana Husková, et al.. (2006). AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension. Journal of Hypertension. 24(12). 2465–2472. 41 indexed citations
20.
Kopkan, Libor, Herbert J. Kramer, Zuzana Husková, et al.. (2005). The role of intrarenal angiotensin II in the development of hypertension in Ren-2 transgenic rats. Journal of Hypertension. 23(8). 1531–1539. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026